Researchers have discovered that psilocybin, a psychedelic compound found in magic mushrooms, may prevent peripheral neuropathy—the debilitating nerve damage and chronic pain that affects many cancer patients undergoing chemotherapy.

Early studies in mice and human tissue show psilocybin's protective effects are so promising that scientists are launching a mid-stage clinical trial this year. This could represent a major breakthrough for the thousands of cancer survivors who struggle with treatment-related nerve damage that often persists long after their chemotherapy ends. Read the full story →

Today's takeaway: What once seemed fringe science is now moving into mainstream medicine—offering hope to cancer patients seeking relief from one of treatment's harshest side effects.